Quarterly Result28 May 2026, 10:49 pm
530199 Board Approves FY26 Results, Recommends ₹0.50 Dividend
AI Summary
The Board of Directors of 530199, at its meeting on May 28, 2026, approved the Audited Standalone and Consolidated Financial Results for the quarter and year ended March 31, 2026. The Board also recommended a final dividend of Re. 0.50 per equity share (50%) for the financial year ended March 31, 2026, aggregating to ₹4,60,50,060, subject to shareholder approval at the forthcoming Annual General Meeting. Additionally, M/s. R. Nanabhoy & Co. was re-appointed as the Cost Auditor for the Financial Year 2026-27.
Key Highlights
- Board approved Audited Standalone and Consolidated Financial Results for FY26.
- Final dividend of Re. 0.50 per share (50%) recommended for FY26.
- Total dividend payout for FY26 amounts to ₹4.61 crore.
- M/s. R. Nanabhoy & Co. re-appointed as Cost Auditor for FY2026-27.
Price Impact
More from THEMISMED